These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 30610670)
1. Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers. Al-Muhtaresh HA; Salem AH; Al-Kafaji G J Cardiovasc Transl Res; 2019 Aug; 12(4):347-357. PubMed ID: 30610670 [TBL] [Abstract][Full Text] [Related]
2. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479 [TBL] [Abstract][Full Text] [Related]
3. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547 [TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study. Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537 [TBL] [Abstract][Full Text] [Related]
5. Circulating miR-130 and its target PPAR-γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus. Yuan Y; Peng W; Liu Y; Xu Z Mol Genet Genomic Med; 2019 Sep; 7(9):e909. PubMed ID: 31368668 [TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease. Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients. Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731 [TBL] [Abstract][Full Text] [Related]
8. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D. Motawae TM; Ismail MF; Shabayek MI; Seleem MM PLoS One; 2015; 10(5):e0126957. PubMed ID: 25978320 [TBL] [Abstract][Full Text] [Related]
10. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease. DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs 342 and 450 together with NOX-4 activity and their association with coronary artery disease in diabetes. Seleem M; Shabayek M; Ewida HA Diabetes Metab Res Rev; 2019 Jul; 35(5):e3130. PubMed ID: 30681251 [TBL] [Abstract][Full Text] [Related]
12. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease. Ding H; Hu CX; Xu JK Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362 [TBL] [Abstract][Full Text] [Related]
13. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study. Rizzacasa B; Morini E; Mango R; Vancheri C; Budassi S; Massaro G; Maletta S; Macrini M; D'Annibale S; Romeo F; Novelli G; Amati F PLoS One; 2019; 14(5):e0216363. PubMed ID: 31059534 [TBL] [Abstract][Full Text] [Related]
14. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease. Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332 [TBL] [Abstract][Full Text] [Related]
15. Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients. Ali Sheikh MS; Xia K; Li F; Deng X; Salma U; Deng H; Wei Wei L; Yang TL; Peng J Biomed Res Int; 2015; 2015():740301. PubMed ID: 25664324 [TBL] [Abstract][Full Text] [Related]
16. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease. Faccini J; Ruidavets JB; Cordelier P; Martins F; Maoret JJ; Bongard V; Ferrières J; Roncalli J; Elbaz M; Vindis C Sci Rep; 2017 Feb; 7():42916. PubMed ID: 28205634 [TBL] [Abstract][Full Text] [Related]
17. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study. Ghaemi F; Rabizadeh S; Yadegar A; Mohammadi F; Asadigandomani H; Bafrani MA; Reyhan SK; Esteghamati A; Nakhjavani M BMC Cardiovasc Disord; 2024 Jun; 24(1):317. PubMed ID: 38914982 [TBL] [Abstract][Full Text] [Related]
18. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease. Chen B; Luo L; Wei X; Gong D; Jin L Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484 [TBL] [Abstract][Full Text] [Related]
19. 12S-hydroxyeicosatetraenoic acid levels link to coronary artery disease in Type 2 diabetic patients. Zhang HJ; Sun CH; Kuang HY; Jiang XY; Liu HL; Hua WF; Liu ZJ; Zhou H; Sui H; Qi R J Endocrinol Invest; 2013 Jun; 36(6):385-9. PubMed ID: 23095287 [TBL] [Abstract][Full Text] [Related]
20. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease. Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]